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INTRODUCTION
Clinical guidelines are developed 
systematically based on best available 
evidence to aid clinical decision making.1 
The use of appropriately validated and tested 
clinical prediction rules (CPRs) is one way 
of implementing evidence-based medicine 
(EBM) for diagnosis and prognosis in clinical 
practice. CPRs are defined as tools that 
quantify the contributions of history, clinical 
examination, and diagnostic tests to stratify 
a patient in terms of the probability of 
having a target disorder (diagnostic CPR) 
or a future health outcome (prognostic 
CPR).1 An example is the Goldman CPR, 
which uses a combination of clinical and 
electrocardiograph findings to risk-stratify 
patients presenting with chest pain as low, 
moderate, or high risk of a cardiac cause.2 
Smaller proportions of CPRs go further 
and recommend management decisions 
based on their algorithms, for instance, 
the modified Centor score for streptococcal 
throat infection stratifies patients based 
on symptoms and clinical signs and then 
uses this to direct the need for antibiotic 
prescription.3,4
However, there are well-recognised 
barriers to implementing CPRs at the point 
of care.5,6 One such barrier is a tendency to 
develop more CPRs for the same clinical 
situation, rather than validating existing 
models.7 The significant increase in 
the publication of CPRs in recent years 
suggests an increased interest on the part 
of researchers at least in such models.8,9 It 
is unclear if this reflects increasing usage 
of these tools in clinical practice or how this 
may vary across clinical areas.
This study investigated whether published 
CPRs have been considered useful by expert 
bodies and at the point of clinical care. 
To answer the first question, a review of 
international clinical guidelines produced on 
behalf of expert bodies was performed, and 
to answer the second, a well-defined group 
of UK clinicians, GPs were surveyed about 
their use of CPRs in selected clinical areas.
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Abstract
Background 
The publication of clinical prediction rules 
(CPRs) studies has risen significantly. It is 
unclear if this reflects increasing usage of these 
tools in clinical practice or how this may vary 
across clinical areas.
Aim
To review clinical guidelines in selected areas 
and survey GPs in order to explore CPR 
usefulness in the opinion of experts and use at 
the point of care. 
Design and setting
A review of clinical guidelines and survey of 
UK GPs.
Method
Clinical guidelines in eight clinical domains 
with published CPRs were reviewed for 
recommendations to use CPRs including 
primary prevention of cardiovascular disease, 
transient ischaemic attack (TIA) and stroke, 
diabetes mellitus, fracture risk assessment 
in osteoporosis, lower limb fractures, breast 
cancer, depression, and acute infections in 
childhood. An online survey of 401 UK GPs was 
also conducted.
Results
Guideline review: Of 7637 records screened by 
title and/or abstract, 243 clinical guidelines met 
inclusion criteria. CPRs were most commonly 
recommended in guidelines regarding primary 
prevention of cardiovascular disease (67%) and 
depression (67%). There was little consensus 
across various clinical guidelines as to which 
CPR to use preferentially. Survey: Of 401 
responders to the GP survey, most were aware 
of and applied named CPRs in the clinical areas 
of cardiovascular disease and depression. The 
commonest reasons for using CPRs were to 
guide management and conform to local policy 
requirements.
Conclusion
GPs use CPRs to guide management but 
also to comply with local policy requirements. 
Future research could focus on which clinical 
areas clinicians would most benefit from CPRs 
and promoting the use of robust, externally 
validated CPRs.
Keywords
clinical prediction rules; clinical guidelines; 
survey.
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METHOD
Review of clinical guidelines 
The aim was to identify clinical guidelines 
in eight selected areas in which the authors 
had prior knowledge that at least one CPR 
potentially relevant to primary care had been 
published: 
• primary prevention of cardiovascular 
disease (CVD);
• TIA/stroke diagnosis and management;
• diabetes mellitus screening, diagnosis or 
risk assessment;
• fracture risk assessment in osteoporosis 
screening and management;
• lower limb fractures diagnosis;
• breast cancer diagnosis, screening, and 
risk assessment;
• depression diagnosis and management; 
and 
• acute childhood infections, namely 
meningitis, influenza, urinary tract 
infection, gastroenteritis, otitis media, 
tonsillitis, pneumonia, and bronchiolitis.
Search strategy. A PubMed search used the 
‘Practice Guideline’ publication type and was 
expanded to include documents with any 
of the words; ‘Guideline[s]’, ‘Framework’, 
‘Standards’, ‘Recommendation[s]’, 
‘Guidance’, ‘Consensus’, ‘Statement’ or 
‘Practice Guideline’ in the title, producing 
a highly sensitive search (n = 106 088). 
To make the search more specific limits 
were applied: English language; exclusion 
of publication types News, Randomized 
Controlled Trial, Meta-Analysis, Clinical 
Trial, Letter and Comment; published 
between 1 June 2000 and 31 May 2010, 
resulting in 41 228 records. This guidelines 
search was then combined with subject-
specific searches designed by researchers 
familiar with each of the clinical domains.
In addition, the websites of the National 
Guideline clearing house, the National 
Institute for Health and Clinical Excellence 
(NICE) and the Scottish Intercollegiate 
Guideline Network (SIGN) were accessed 
and searched (included as additional 
sources in Appendices 1a and 1b).
Study selection. Documents identified 
from these subject-specific searches were 
eligible for inclusion if they met the following 
criteria: (a) contains systematically developed 
statements that include recommendations, 
strategies, or information that assists 
clinicians and patients to make decisions 
about appropriate health care for specific 
clinical presentations; (b) produced by 
medical speciality associations — relevant 
professional societies, public or private 
organisations, government agencies, or 
healthcare providers at the state, national, or 
international level; (c) full text freely available 
in print or electronic format; and (d) current 
and most recent available version of the 
guideline available. Documents identified 
by the search and meeting the above four 
criteria were considered to be ‘clinical 
guidelines’ for the purposes of this review.
The difficulty of formally defining CPRs 
has been discussed previously.8 For the 
purposes of this review, a pre-existing 
definition10 was adapted to define a clinical 
prediction rule as ‘a predefined combination 
of (two or more) questions, symptoms, signs 
and tests that provides information on risk, 
diagnosis, or prognosis’. Formal diagnostic 
criteria were not considered to be CPRs. 
For the purposes of this review, a CPR 
was considered to be ‘predefined’ if the 
guideline cites an article on the CPR in a 
peer-reviewed journal. 
Data extraction. In each clinical area, one 
researcher searched through titles and 
abstracts for their specific search. Each 
potentially relevant full-text article was 
independently reviewed in duplicate and 
relevant data extracted. To be considered to 
be ‘recommended’ by the guideline, use of 
language that recommends, encourages, or 
promotes the use of the CPR was required. 
Discrepancies were resolved by consensus 
or by a third adjudicating reviewer. For each 
clinical area the total number of guidelines 
retrieved, the number and proportion 
recommending use of at least one CPR, and 
the most commonly recommended CPRs 
are reported. For the acute infections in 
How this fits in
The use of appropriately validated and 
tested clinical prediction rules (CPRs) is 
one way of implementing evidence-based 
medicine for diagnosis and prognosis in 
clinical practice and publication of CPRs 
has risen significantly. This study showed 
that recommendation of CPRs by clinical 
guidelines varied according to clinical 
area. Surveyed GPs reported using CPRs 
most frequently in the clinical domains of 
cardiovascular disease and depression, 
primarily to guide management and adhere 
to local policy requirements. Future efforts 
could focus on determining in which areas 
of practice CPRs would be most beneficial 
for clinicians and patients, and promoting 
the use of robust, externally validated CPRs.
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children domain, guidelines were included if 
children were mentioned specifically in the 
title or if the guideline could be applied to 
both adults and children.
Survey of GPs
Participants. Participants were GPs in the 
UK, registered with the General Medical 
Council, recruited from Doctors.net.uk. To 
estimate the percentage using each CPR 
with a standard error of approximately 2.5%, 
a sample size of 400 GPs stratified by NHS 
Strategic Health Authority and seniority/
position was requested. Doctors.net.uk 
sent invitations to members followed by 
reminders until 400 GPs had completed the 
questionnaire. Participants were asked for 
their year of qualification, and role in the 
practice.
Survey. In consultation with academic GP 
colleagues, 25 CPRs potentially relevant 
to UK general practice were selected. 
Modifications made after the in-house pilot 
included the addition of four CPRs: one of 
these, the NICE traffic light algorithm for 
childhood infection, did not meet the criteria 
for a CPR in the review of guidelines, but 
was considered a CPR by participants in 
the pilot survey. The resulting 29 included 
CPRs were grouped under six clinical areas, 
for presentation to survey responders, as 
shown in Table 1. Pragmatic considerations 
regarding survey length precluded the 
inclusion of all clinical areas studied in the 
first part of this study. Responders were 
asked which CPRs they had heard of and 
how often they used them. They were asked 
for reasons why they did or did not use each 
CPR, using the following options: (a) aid 
diagnosis; (b) assessing severity; (c) to guide 
therapy; (d) to guide referral; (e) comply 
with clinical guidelines/Quality Outcomes 
Framework (QOF); (f) automatically 
generated by practice software; and (g) 
inform or educate patients. A free text field 
was provided for other reasons for not using 
CPRs or to indicate any additional CPRs not 
included in the survey.
RESULTS
Review of clinical guidelines
An overview of the search strategy is 
presented in Appendix 1a and 1b. A total of 
7637 records were screened by title and/or 
abstract and 243 eligible clinical guidelines 
in eight clinical areas were identified and 
included in the review.
A summary of clinical guideline numbers 
retrieved and named CPRs recommended 
according to clinical domain is presented in 
Table 2. Overall, CPRs were most commonly 
recommended in the clinical domains 
of primary prevention of cardiovascular 
disease (67%), depression (67%), TIA/
stroke (63%), and breast cancer (51%). 
For lower limb fractures and fracture risk 
assessment in osteoporosis, CPRs were 
recommended in 40% and 38% of reviewed 
Table 1. List of clinical prediction rules (CPRs) included in the survey
Clinical area Clinical prediction rule Description Reference
Cardiovascular QRISK or QRISK2 10-year risk of heart attack or stroke,  21 
disease    based on QRESEARCH database 
 Joint British Societies (JBS) Based on Framingham risk 22 
 charts    equation with adjustments 
 New Zealand (NZ) Tables Cardiovascular Risk Calculator from 23 
    the New Zealand Guidelines Group 
 Sheffield Tables Based on Framingham risk function 24 
 Any Framingham Risk Score Cardiovascular risk assessment, 25 
    based on Framingham study 
 Systematic Coronary Risk The European cardiovascular disease 26 
 Evaluation (SCORE) risk charts   risk assessment model 
 PROCAM risk score Cardiovascular risk assessment, 27 
    based on Prospective Cardiovascular 
    Münster (PROCAM) Study
Anxiety and Patient Health Questionnaire 2-item version of PHQ-9 28 
depression (PHQ)-2 
 Patient Health Questionnaire 9-item depression module of the PHQ 29 
 (PHQ)-9 
 Generalised Anxiety Scale (GAD)-2 2-item subscale of GAD-7 30 
 Generalised Anxiety Scale (GAD)-7 7-item anxiety measure 30 
 Hospital anxiety and depression Self-reported rating instrument 31 
 scale (HADs)    for anxiety and depression 
 Beck Depression Inventory (BDI) Self-reported items, each correlating to 32 
    a symptom of major depressive disorder 
    experienced over the preceding 2 weeks
Fracture Ottawa ankle rule Decision rule for the selective use 33 
    of radiography in acute ankle injuries 
 Ottawa knee rule Decision rule for the selective use 34 
    of radiography in acute knee injuries  
 Ottawa foot rule (Also known as the Ottawa ankle rule) 33 
 Pittsburgh knee rule Decision rule for the selective use 35 
    of radiography in acute knee injuries
Cancer Gail risk score Breast cancer risk assessment tool 36 
 Risk Assessment in Genetics Evaluation of genetic risk of cancer 37 
 (RAGs)
Infection Yale Observation scales to identify serious 38 
    illness in febrile children 
 NICE traffic light system From the NICE guideline on feverish 39 
    illness in children 
 CRB65 Grades severity of community-acquired 17 
    pneumonia in terms of 30-day mortality 
 STREP score Modified Centor Score for Streptococcal 40 
    Pharyngitis in children and adults 
 CENTOR score Diagnosis of Streptococcal Pharyngitis 3 
    in adults
General medical ABCD or ABCD2 score Prediction of very early stroke risk 41 
    after transient ischaemic attack at 7 days 
 California score Risk of stroke at 90 days 42 
 CHADS or CHADS2 Atrial fibrillation stroke risk 43 
 Wells score (DVT) Risk of deep vein thrombosis 44 
 Wells score (PE) Risk of pulmonary embolism 45
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Table 2. Clinical guidelines review of clinical prediction rules (CPRs) recommendations
 Total number CPR    Other CPRs 
 of guidelines recommended  recommended not 
Clinical area included (%) Named CPRs recommended (number of guidelines) in clinical domain
Cardiovascular 45 30 (67) Risk scores derived from the Framingham Heart Study (21);25 None 
disease (primary   Systematic Coronary Risk Evaluation (SCORE) tool (5) ;26  
prevention)   UK Prospective Diabetes Study (UKPDS) Risk Engine (4); 46 
   Risk stratification system of the 2003 European Society of Cardiology (3); 47
   CHADS or CHADS2 score (2);43 Cardiovascular Life Expectancy model (2); 48 
   Heartscore (1);26 Reynolds Risk Score (1); 49ASSIGN (1); 50
   Risk stratification system 1999 World Health Organization guidelines (1).51
Transient ischaemic 16 10 (63) ABCD or ABCD2 (5);41,52 Framingham risk score (1);53 For depression (GHQ12, PHQ9
attack (TIA) or stroke   FAST (Facial weakness, Arm weakness, Speech difficulty, and SAD-Q), for malnutrition 
(diagnosis and    Time to act) (6);54  Rule Out Stroke in the Emergency Room (MUST) and the
management)   (ROSIER) (5); 55Melbourne acute stroke scale (MASS) (1).56 Glasgow Coma Scale 19,29,57–59
Diabetes mellitus 20 4 (20) Finnish Diabetes Risk Score (FINDRISC) (3); 60 For cardiovascular 
(Screening, risk   Diabetes Risk Calculator (1).61 risk assessment 
assessment or diagnosis)    (Framingham risk score) 25
Osteoporosis (Fracture 25 9 (38) WHO/FRAX algorithm (5);62 None 
risk assessment)   Osteoporosis Risk Assessment Index (2); 13  
   Simple Calculated Osteoporosis Risk Estimation questionnaire (1); 63  
   Two ultrasound indices; the stiffness index and the 
   quantitative ultrasound index (1).
Lower limb fractures 20 8 (40) Ottawa Ankle Rule (2); 33 None 
(Diagnosis and   Ottawa Knee rule (4);34 
management)   Meniscal Pathology Composite score (1);64 
   Function Score of De Bie (1) 4. 65
Acute childhood 73 12 (16) Tonsillitis: Centor score (3);3 Glasgow Coma Scale 19 
infections a (Diagnosis    Pneumonia: CURB-65 (5);17   
and management)   Pneumonia Severity Index/Patient Outcome Research Team (PORT) (5); 66 
   World Health Organization (WHO) criteria (1); 67 
   Meningitis: Glasgow meningococcal septicaemia prognostic score (2); 68 
   Bacterial meningitis score (2);  69  Hoen’s software (1); 70 
   Meningitest (1).71
Breast cancer (Risk  32 16 (51) Original or modified Gail model (5); 72 None 
assessment, screening   Claus model (4); 73  
and referral)   BRCAPRO (4); 74  
   Mammaprint tool (3); 75  
   Oncotype Diagnosis Recurrence score (3); 76  
   Adjuvant Risk score (3); 77  
   Nottingham Prognostic Index (1); 78  
   Manchester Score (1); 79  
   Risk Assessment in Genetics (RAGS) Tool (1); 37  
   Family History Risk Assessment Tool (1); 80  
   Tyrer Tool (1). 81 
Depression (Diagnosis 12 8 (67) Patient Health Questionnaire (PHQ)-9 (4); 29 CAGE-AID 90 
and management)   Two-item screener (4); 28  
   Hamilton Rating Scale for Depression (3); 82  
   Beck Depression Inventory (BDI) (2); 32  
   Montgomery Asberg Depression Rating Scale (MADRS) (2); 83  
   Edinburgh Postnatal Depression Inventory (EPDI) (1); 11   
   Quick Inventory of Depressive Symptomatology (QID-SR) (1); 84  
   Cornell Scales for Depression in Dementia (CSDD) (1); 85  
   Bech-Rafaelsen Melancholia Scale (BRMS) (1); 86  
   Hospital Anxiety and Depression Scale (HADS) (1); 31  
   Clinical Global Impressions (CGI) scale (1); 87  
   Geriatric Depression Scale (GDS) (1); 88  
   Centre for Epidemiological Studies Depression Scale (CES-D) (1).89
 aFor the acute childhood infections of otitis media, bronchiolitis, gastroenteritis, urinary tract infection, and influenza, no CPR recommendations were found in reviewed 
guidelines.    
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guidelines respectively. CPRs were 
least often recommended in the clinical 
domains of diabetes mellitus (20%) and 
acute childhood infections (16%). Overall, 
there was little consensus across reviewed 
guidelines as to which, if any, CPR to use 
preferentially.
Survey of UK GPs
A total of 401 responses were collected 
from Scotland (12%), Northern Ireland (3%), 
Wales (4.5%), and England (80.5%), spread 
among each of the 10 English Strategic 
Health Authority regions. Participants 
qualified between 1969 and 2005 (median 
1995) and most (65%) were GP principals 
or partners. Figure 1 shows the reported 
frequency of use of any CPRs in each 
clinical domain, of specific CPRs indicated 
by name, and of other CPRs not included 
in the questionnaire design but named by 
responders in the free text field. In CVD 
these other CPRs included ASSIGN (n = 23 
GPs, all based in Scotland) and the UKPDS 
Risk Engine (n = 1). In depression, other 
CPRs included the Edinburgh Postnatal 
Depression Scale (24 GPs) and Mini-Mental 
State Examination for dementia (n = 3).11,12 
In addition to the fracture CPRs listed in 
the questionnaire, seven used the FRAX 
tool for osteoporosis.13 In cancer, additional 
CPRs mentioned were the Gleason score 
for prostate cancer staging (n = 13 GPs),14 
Dukes staging for colorectal cancer (n = 5),15 
and the Tumour Nodes Metastases cancer 
staging system (n = 4).16 In addition to 
infection CPRs listed in the survey, five 
(1%) reported using the CURB65 score17 
and two (0.5%) reported having used the 
APACHE II score for ICU mortality.18 In the 
section entitled general medical, additional 
CPRs mentioned were the Glasgow Coma 
Scale (n = 11 GPs), Epworth sleepiness 
scale (n = 5), and Rockall score for risk 
of upper gastrointestinal bleeding (n = 3).19 
Responders additionally used the free text 
to report using the International Prostate 
Symptom Score for benign prostatic 
hyperplasia (n = 7),20 various alcohol use 
questionnaires (n = 6), and others (all 
n≤2). Reported reasons for CPR use are 
presented in Table 3. 
Depression
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Figure 1. Self-reported use of clinical prediction 
rules by 401 UK GPs in selected clinical areas. 
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The main reason for not using named 
CPRs related to lack of familiarity 
(Table 4). Other reasons, reported in free 
text fields, included preference for own 
clinical judgement (for CPRs listed under 
depression, infection, and general medical), 
greater relevance to secondary care settings 
(fracture and cancer), and perceived lack of 
utility (depression and cancer).
DISCUSSION
Summary
Of the eight clinical domains studied, 
guidelines most commonly recommended 
CPRs for primary prevention of CVD and 
depression. For CVD, a total of 10 different 
cardiovascular risk assessment models 
were recommended, most commonly those 
derived from the Framingham Heart Study. 
Surveyed GPs reported using these tools in 
practice also, with most using Framingham 
derived scores, the Joint British Societies 
risk score, or QRISK, primarily to guide 
therapy. Other reported reasons for use 
of these CPRs were to inform or educate 
patients, comply with guidelines/Quality and 
Outcomes Framework (QOF), and to assess 
disease severity. For depression, a total of 
13 different models were recommended in 
eight reviewed guidelines, most commonly 
the PHQ-9. This was also utilised by most 
of the surveyed GPs who indicated that 
guideline or QOF conformance was the 
most common reason for use, followed 
by assessing severity and as a diagnostic 
aid. The Ottawa ankle rule for ankle 
fracture assessment, although infrequently 
recommended by reviewed guidelines, 
was used by most of the surveyed GPs, 
primarily to aid diagnosis. For breast cancer, 
although about half of reviewed guidelines 
recommended the use of a CPR model 
for risk assessment, these tools were 
very infrequently utilised by surveyed GPs. 
Most were either unaware of these tools 
or preferred to use UK referral guidelines, 
which dictate that suspected cancer cases 
need specialist review within 2 weeks.
Both the survey and review suggest that 
there are varying influences regarding use 
of CPRs in clinical practice. Use of these 
tools may vary geographically as illustrated 
by the guidelines review, where the QRISK2 
score was recommended by UK guidelines 
only, and within the UK by the survey, 
with the ASSIGN algorithm being used 
exclusively by Scottish GPs. As already 
mentioned, national policy requirements 
in UK general practice also have an 
impact on CPR uptake. Overall, a lack of 
familiarity, preference for their own clinical 
judgement, or considering the CPR to be 
unnecessary were highlighted by surveyed 
GPs as the main impediments for use of 
these tools at the point of care. Examining 
Table 3. Number (%) of GPs reporting respective reasons for using 
clinical prediction rules
 Cardiovascular Anxiety and    General 
 disease,  depression Fracture Cancer Infection medical 
 n (%) n (%) n (%) n (%) n (%) n (%)
Aid diagnosis 143 (36) 217 (54) 225 (56) 48 (12) 92 (23) 219 (55)
Assessing severity 191 (48) 279 (70) 66 (16) 39 (10) 168 (42) 142 (35)
To guide therapy 336 (84) 207 (52) 64 (16) 30 (7) 118 (29) 188 (47)
To guide referral 89 (22) 134 (33) 146 (36) 59 (15) 106 (26) 218 (54)
Comply with clinical 267 (67) 313 (78) 17 (4) 21 (5) 37 (9) 106 (26) 
guidelines/QOF
Automatically generated 106 (26) 31 (8) 4 (1) 4 (1) 1 (0.002) 19 (5) 
by practice software
Inform or educate 220 (55) 123 (31) 50 (12) 30 (7) 44 (11) 75 (19) 
patients
Other 1 (0.002) 8 (2) 8 (2) 2 (0.005) 1 (0.002) 3 (1)
QOF = Quality and Outcomes Framework.
Table 4. Number (%) of GPs who do not use the respective clinical 
prediction rules and of these, the number (%) who had never heard 
of them
  Do not use Never heard 
Clinical area CPR n (%) of it, n (%)
Cardiovascular QRISK or QRISK2 140 (35) 88 (22) 
disease Joint British Societies (JBS) risk charts 78 (19) 33 (8) 
 JBS risk calculator 152 (38) 96 (24) 
 New Zealand tables 355 (89) 313 (78) 
 Framingham risk score 58 (14) 6 (1) 
 Systematic Coronary Risk Evaluation (SCORE) 364 (91) 332 (83) 
 PROCAM 98 (393) 94 (378) 
Anxiety and Patient Health Questionnaire (PHQ)-2 292 (73) 251 (63) 
depression PHQ9 33 (8) 17 (4) 
 Generalised Anxiety Scale (GAD)-2 318 (79) 246 (61) 
 GAD7 247 (62) 152 (38)  
 Hospital and Anxiety Depression scale (HADs)  198 (49) 54 (13) 
 Beck Depression Inventory (BDI) 287 (72) 108 (27) 
Fracture Ottawa ankle 125 (31) 83 (21) 
 Ottawa knee 315 (79) 284 (71) 
 Ottawa foot 312 (78) 289 (72) 
 Pittsburgh knee 390 (97) 378 (94)
Cancer Gail risk score 377 (94) 363 (91) 
 Risk Assessment in Genetics (RAGs) 365 (91) 346 (86)
Infection Yale 391 (98) 387 (97) 
 NICE traffic light 213 (53) 172 (43) 
 CRB65 320 (80) 313 (78) 
 STREP score 390 (97) 386 (96) 
 Centor score 323 (81) 305 (76)
General medical ABCD or ABCD2 194 (48) 173 (43) 
 California score 394 (98) 386 (96) 
 CHADS or CHADS2 230 (57) 208 (52) 
 Wells score for DVT 163 (41) 139 (35) 
 Wells score for PE 247 (62) 228 (57)
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the level of evidence for all CPRs included 
in this review was beyond the scope of this 
study. However, it is interesting to note 
that the Centor score for streptococcal 
throat infection, which has been broadly 
validated for use in general practice, was 
not used by most GPs (81%), with 76% of 
these reporting they had never heard of it, 
whereas the NICE traffic light system for 
the assessing childhood fever, which was 
developed for the purposes of the guideline, 
was used by almost half of the surveyed 
GPs. CPR use also varied according to 
clinical area, for example the CHADS and 
CHADS2 score for the prediction stroke 
risk in patients with atrial fibrillation and 
the Well’s score for DVT were not utilised 
by most surveyed GPs, although most were 
familiar with these CPRs.
Clinical guidelines offer scope to critically 
appraise published CPRs, which could help 
clinicians in making an informed decision 
regarding their use. However, in this review 
there was little such evaluation of CPRs 
evident and little consensus between 
guidelines as to which, if any, of these tools 
should be used preferentially.
Strengths and limitations
This study reviews wide-ranging 
international literature supplemented by a 
detailed survey of actual clinical practice 
in UK general practice. Each review was 
designed by a researcher with experience 
in the relevant area. The pre-selection 
of clinical domains in which CPRs exist 
allows comparison in terms of guideline 
recommendations and use in practice.
There are several limitations. First, for the 
purpose of rigorous review it was necessary 
to adopt a single, objective definition of a 
CPR. As there is no internationally agreed 
definition of a CPR, the definition used 
should be considered a working definition 
for a specific project rather than definitive for 
all purposes. Second, the literature review, 
of international scale and across eight 
clinical areas, is supplemented by a survey 
of primary care in a single national setting. 
The authors did not have the resources to 
conduct an international survey of primary, 
secondary, and tertiary care, and this led to 
a UK survey that looked at fewer CPRs than 
the literature review. Finally, the electronic 
survey mechanism used for this study gives 
no known denominator and represents a 
partially self-selecting population.
Comparison with existing literature
Previous studies of clinical prediction rules 
across multiple domains have assessed the 
properties of the rules, such as validity 
and impact, rather than their uptake by 
practicing clinicians7,9 Surveys of the uptake 
of CPRs have usually been restricted to 
single clinical domains.91–94 To the author’s 
knowledge this is the first large survey 
to compare the uptake of CPRs across 
multiple clinical domains and to relate 
this to a systematic evaluation of guideline 
recommendations.
Implications for research and practice
From a clinical perspective, CPRs were 
applied by surveyed GPs most frequently in 
the clinical domains of CVD and depression 
mainly to guide management and adhere 
to local policy requirements. Lack of 
awareness was cited as one of the reasons 
for not using CPRs in practice. Future 
efforts could focus on determining in which 
areas of practice CPRs would be most 
beneficial to clinicians and patients, for 
example, referral guidance at the primary–
secondary care interface for high stakes 
diagnoses such as myocardial infarction 
and cancer. In addition, the implementation 
of poorly validated CPRs should be resisted. 
Research should instead be directed to 
developing robust, externally validated 
CPRs that have been shown to have a 
positive impact on the process and outcome 
of clinical care. It is these CPRs that should 
be promoted in clinical guidelines.
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